Nobivac FeLV, Suspension for Injection for Cats

Transient and small thickening or nodule, approximately 5 - 10 mm in size, may be
observed at the injection site and disappear within 2 to 6 weeks without treatment.
Occasionally, systemic reactions (hyperthermia, anorexia, lethargy) may occur within
one or two days after vaccine administration.
and diarrhoea) may also be commonly observed.
Where Nobivac FeLV has been used to reconstitute cat vaccines in the Nobivac range
containing feline calicivirus (F9 strain), feline rhinotracheitis virus (G2620A strain) and/or
feline panleucopenia virus (MW-1 or Bristol strain) prior to inoculation, a small nodule at
the site of vaccination is frequently observed. It can persist for up to 18 days post-
inoculation. Occasionally, the nodule may be painful for up to 6 days after injection. A
transient rise in body temperature or lameness may occur and last up to 3 days post
vaccination. In some cases, a slight dullness or reduced appetite may be observed for
up to 1 day post vaccination.
In the rare event of hypersensitivity reaction following vaccination, administer an
antihistamine, corticosteroid or adrenaline without delay and by the most-immediate
route.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reactions)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).